Svmuureports that Moderna, the American pharmaceutical giant, has announced it has begun developing a hantavirus vaccine, with the work currently in its early stages. The statement said Moderna has partnered with the U.S. Army Medical Research Institute of Infectious Diseases to conduct early research on a hantavirus vaccine.
Additionally, Moderna has been collaborating with the Vaccine Innovation Center at Korea University College of Medicine to develop potential immunization regimens. This research began before the outbreak on the "Hondius" ship. Moderna stated: "These efforts are still in their early stages and are ongoing." (Golden Ten)
Moderna: Developing Hantavirus Vaccine
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Analysis of TB Coin’s Value: Multiple Projects Share the Same Code, but Investment Potential Varies
-
2
What is ANTS? It is a shared symbol used by multiple projects; be sure to verify which one you are investing in before proceeding.
-
3
When Will the Uniswap Decentralized Exchange Launch? An Analysis of Its Origins and Core Mechanisms
-
4
What Is KNC? An Analysis of the Functions and Trading Platform of KNC, the Core Token of Kyber Network
-
5
LTC Litecoin: A Review of Price Trends and Halving Events Over the Past Seven Years (2019–2026)
-
6
What Is VSC? An Overview of the Vyvo Coin (VSC) Project and Its Current Market Status
-
7
GHC (Galaxy Heroes Coin) Value Analysis: Project Overview and Investment Considerations
-
8
HTX (formerly HTX) Platform Overview and Recommendations for Legitimate Bitcoin Trading and Wallet Software
-
9
WPC Coin Analysis: The Current Status and Future Prospects of World Peace Coin and WePiggy Coin
-
10
Analysis of OZONE Token Value: Distinguishing the Investment Potential of Ozonechain (OZO) and Ozone Metaverse ($OZONE)
Markets Today
Recommended Reading












